Extending the term of exclusive access to clinical trial data will raise drug costs in the short term but also help approve 200 extra drugs and result in greater life expectancy in the long term, ...

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the presentation of new ...

Revolutionary AI assistant RISA eliminates the pain of hunting for patient data across multiple systems, enabling clinicians to focus more on patient care ThetaRho.ai, a provider of AI-powered ...

WILMINGTON, Del., March 03, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a leading AI-powered physician enablement platform, today announced it has partnered with Google Cloud to ...

Evolving Landscape of Parenteral Anticancer Therapy–Associated Lung Toxicity: Incidence, Monitoring, and Management This scoping review was conducted based on the Arksey and O'Malley framework and the ...

The FDA has initiated its first 'real-time' clinical trial, enabling regulators to monitor safety signals and clinical endpoints as they occur via cloud-based imaging and data feeds. The pilot, ...

The speed of medicine has changed. Healthcare professionals are no longer waiting for conferences or clinical guidelines to make key decisions. In fast-paced clinical settings, physicians are actively ...

Making health data more accessible to patients – not to mention doctors and health plans – is a priority for all hospitals and health systems today, as the final Centers for Medicare and Medicaid ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

New functionality within Counterpart Assistant uses Google Cloud’s Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data WILMINGTON, Del., March 03, ...